(Alliance News) - Healthcare-focused investment firm Syncona Ltd said Monday that portfolio company Freeline Therapeutics has published 12-month data from an ongoing trial in haemophilia B, and a Read More
(Alliance News) - Investment firm Syncona Ltd on Thursday said it has agreed to sell its portfolio company Blue Earth Diagnostics to Bracco Imaging for USD450 million plus closing adjustment at in Read More
(Alliance News) - Life sciences investor Syncona Ltd on Thursday reported a "strong" annual performance, with core life sciences firms doing well, while it is also to halt is paying a to Read More
LONDON (Alliance News) - Healthcare company Syncona Ltd on Tuesday said Melanie Gee will take over the chair of its board from Jeremy Tigue over the coming months in preparation for Tigue's at Read More
LONDON (Alliance News) - Healthcare company Syncona Ltd said Monday it has established a new cell therapy company, Quell Therapeutics, with GBP35 million financing commitment.Syncona has - Read More
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - up 1.8%. The telecommunications firm said it Read More
LONDON (Alliance News) - Syncona Ltd on Tuesday said it was encouraged by portfolio firm Blue Earth Diagnostics prostate cancer imaging tests results.The healthcare company said that a on a Read More
LONDON (Alliance News) - Syncona Ltd on Thursday said that a merger between its two units Gyroscope Therapeutics and Orbit Biomedical created the first fully integrated retinal gene therapy will a Read More
LONDON (Alliance News) - The Wellcome Trust Ltd on Wednesday said it will sell a small percentage of its shareholding in Syncona Ltd by way of a placing.The placing is expected to include a Read More
LONDON (Alliance News) - Life sciences investor Syncona Ltd on Tuesday said it will significantly reduce its fund investments over the next three to six months as it works to simplify the of its a Read More
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday:----------FTSE 100 - up 4.2%. Shares in the company were from on - Read More
LONDON (Alliance News) - Syncona Ltd on Monday said investee company Nightsar Therapeutics PLC has agreed to be acquired by neuroscience healthcare firm Biogen Inc for USD877 million, giving a 72% Read More
LONDON (Alliance News) - FTSE 250-listed healthcare-focused investor Syncona Ltd on Monday reported on progress made by portfolio company, Nasdaq-listed Autolus Therapeutics Inc, on its has dosed Read More
LONDON (Alliance News) - Syncona Ltd on Wednesday reported a more than doubled profit for the first half of its financial year, boosted by fair value gains amid a strong total return for the the a Read More
LONDON (Alliance News) - Healthcare-focused investment firm Syncona Ltd said Friday it has invested a further USD18 million in NASDAQ-listed Nightstar Therapeutics PLC after its announced a share Read More
LONDON (Alliance News) - FTSE 250-listed healthcare investor Syncona Ltd said on Monday its portfolio company Nightstar Therapeutics PLC reported positive results from the dose escalation study in Read More
LONDON (Alliance News) - Healthcare investor Syncona Ltd said Thursday its net assets increased significantly in its financial first quarter, due to the strong performance and increasing size of a Read More
LONDON (Alliance News) - FTSE 250-listed healthcare investment company Syncona Ltd said on Tuesday it has invested GBP85 million in Adeno-associated virus gene therapy company virus is a small and Read More
